Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2025-12-24 @ 3:04 PM
NCT ID:
NCT02740959
Eligibility Criteria:
Inclusion Criteria:
* Patients who signed the informed consent form
* The age of eligible patients should be 20 years old.
* Eligible patients must have locally advanced or metastatic cancer or inoperable advanced cancer.
* Patients are under standard palliative care (SPC) at hospice setting and have no further curative options available.
* Patients with BFI fatigue score 4 during screening.
* Patients have a life expectancy of at least 3 months as determined by the investigator.
* Patient must be willing and able to complete quality of life questionnaires.
Exclusion Criteria:
* Female patients are pregnant or breast-feeding.
* Patients with uncontrolled systemic disease such as active infection, severe heart disease, uncontrollable hypertension or diabetes mellitus.
* Patients take central nervous system stimulators such as Methylphenidate within 30 days before screening.
* Patients have enrolled or have not yet completed other investigational drug trials within 30 days before screening.
* Patients with Karnofsky Performance Scores less than 30 % at time of screening
* Patients who are diagnosed as dying status
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT02740959
Study Brief:
Protocol Section:
NCT02740959